{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:04:46Z","timestamp":1791317086473,"version":"4.3.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T00:00:00Z","timestamp":1204243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1007\/s11064-008-9610-3","type":"journal-article","created":{"date-parts":[[2008,2,29]],"date-time":"2008-02-29T10:00:49Z","timestamp":1204279249000},"page":"1717-1723","source":"Crossref","is-referenced-by-count":151,"title":["Free Copper, Ferroxidase and SOD1 Activities, Lipid Peroxidation and NO x Content in the CSF. A Different Marker Profile in Four Neurodegenerative Diseases"],"prefix":"10.1007","volume":"33","author":[{"given":"Marie-Catherine","family":"Boll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireya","family":"Alcaraz-Zubeldia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Montes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Rios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,2,29]]},"reference":[{"issue":"suppl","key":"9610_CR1","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1038\/399a003","volume":"399","author":"DL Price","year":"1999","unstructured":"Price DL (1999) New order from neurological disorders. Nature 399(suppl):A3\u2013A5","journal-title":"Nature"},{"key":"9610_CR2","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","volume":"59","author":"B Halliwell","year":"1992","unstructured":"Halliwell B (1992) Reactive oxygen species in the central nervous system. J Neurochem 59:1609\u20131623","journal-title":"J Neurochem"},{"key":"9610_CR3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1172\/JCI200317638","volume":"111","author":"H Ischiropoulos","year":"2003","unstructured":"Ischiropoulos H, Beckman JS (2003) Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J Clin Invest 111:163\u2013169","journal-title":"J Clin Invest"},{"key":"9610_CR4","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.42.12.2241","volume":"42","author":"P Jenner","year":"1992","unstructured":"Jenner P, Schapira AH, Marsden CD (1992) New insights into the cause of Parkinson\u2019s disease. Neurology 42:2241\u20132250","journal-title":"Neurology"},{"key":"9610_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI200317741","volume":"111","author":"EA Schon","year":"2003","unstructured":"Schon EA, Manfredi G (2003) Neuronal degeneration and mitochondrial dysfunction. J Clin Invest 111:303\u2013312","journal-title":"J Clin Invest"},{"key":"9610_CR6","first-page":"155","volume":"53","author":"MBH Youdim","year":"1990","unstructured":"Youdim MBH, Ben Shachar D, Yehuda S, Riederer P (1990) The role of iron in the Basal Ganglion. Adv Neurol 53:155\u2013162","journal-title":"Adv Neurol"},{"key":"9610_CR7","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1002\/ana.410320716","volume":"32","author":"DT Dexter","year":"1992","unstructured":"Dexter DT, Jenner P, Schapira AHV, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. Ann Neurol 32:S94\u2013S100","journal-title":"Ann Neurol"},{"key":"9610_CR8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1600-0773.1995.tb00160.x","volume":"76","author":"C Rios","year":"1995","unstructured":"Rios C, Alvarez-Vega R, Rojas P (1995) Depletion of copper and manganese in brain after MPTP treatment of mice. Pharmacol Toxicol 76:348\u2013352","journal-title":"Pharmacol Toxicol"},{"key":"9610_CR9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1007680616056","volume":"26","author":"M Alcaraz-Zubeldia","year":"2001","unstructured":"Alcaraz-Zubeldia M, Rojas P, Boll C, Rios C (2001) Neuroprotective effect of acute and chronic administration of copper (II) sulfate against MPP+ neurotoxicity in mice. Neurochem Res 26:59\u201364","journal-title":"Neurochem Res"},{"key":"9610_CR10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(87)90827-0","volume":"2","author":"HS Pall","year":"1987","unstructured":"Pall HS, Williams AC, Blake DR et\u00a0al (1987) Raised cerebrospinal-fluid copper concentration in Parkinson\u2019s disease. Lancet 2:238\u2013241","journal-title":"Lancet"},{"key":"9610_CR11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3940(99)00221-9","volume":"265","author":"MC Boll","year":"1999","unstructured":"Boll MC, Sotelo J, Otero E, Alcaraz-Zubeldia M, Rios C (1999) Reduced ferroxidase activity in the CSF from patients with Parkinson\u2019s disease. Neurosci Lett 265:155\u2013158","journal-title":"Neurosci Lett"},{"key":"9610_CR12","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotid repeat that is unstable on Huntington\u2019s disease chromosomes. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9610_CR13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1994","unstructured":"McKhann G, Drachman D, Folstein M et\u00a0al (1994) Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer\u2019s disease. Neurology 34:939\u2013944","journal-title":"Neurology"},{"key":"9610_CR14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ana.410380114","volume":"38","author":"JD Rothstein","year":"1995","unstructured":"Rothstein JD, Van Kammen M, Levey AI, Martin J, Kuncl JW (1995) Selective loss of glial glutamate transporter GTL1 in amyotrophic lateral sclerosis. Ann Neurol 38:73\u201384","journal-title":"Ann Neurol"},{"key":"9610_CR15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0197-4580(03)00085-X","volume":"25","author":"C Zoia","year":"2004","unstructured":"Zoia C, Cogliati T, Tagliabue E et\u00a0al (2004) Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer\u2019s disease. Neurobiol Aging 25:149\u2013157","journal-title":"Neurobiol Aging"},{"key":"9610_CR16","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s007020050084","volume":"105","author":"L Zecca","year":"1998","unstructured":"Zecca L, Rosati M, Renella R et\u00a0al (1998) Nitrite and nitrate levels in cerebrospinal fluid of normal subjects. J Neural Transm 105:627\u2013633","journal-title":"J Neural Transm"},{"key":"9610_CR17","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/clinchem\/38.12.2449","volume":"38","author":"R Naidoo","year":"1992","unstructured":"Naidoo R, Knapp ML (1992) Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis and other conditions. Clin Chem 38:2449\u20132454","journal-title":"Clin Chem"},{"key":"9610_CR18","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/362059a0","volume":"362","author":"DR Rosen","year":"1993","unstructured":"Rosen DR, Siddique T, Patterson D et al (1993) Mutations in Cu\/Zn superoxide dismutase are associated with familiar amyotrophic lateral sclerosis. Nature 362:59\u201362","journal-title":"Nature"},{"key":"9610_CR19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/nbdi.1999.0250","volume":"6","author":"DJ Waggoner","year":"1999","unstructured":"Waggoner DJ, Bartnikas TB, Gitlin JD (1999) The role of copper in neurodegenerative diseases. Neurobiol Dis 6:221\u2013230","journal-title":"Neurobiol Dis"},{"key":"9610_CR20","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1073\/pnas.92.7.2539","volume":"92","author":"ZL Harris","year":"1995","unstructured":"Harris ZL, Takahashi Y, Miyajima H, Serizawa M, McGiliwray RTA, Gitlin JD (1995) Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci USA 92:2539\u20132543","journal-title":"Proc Natl Acad Sci USA"},{"key":"9610_CR21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1399-0004.1997.tb02459.x","volume":"51","author":"ME Alonso","year":"1997","unstructured":"Alonso ME, Yescas P, Cisneros B et\u00a0al (1997) Analysis of the (CAG)n repeat causing Huntington\u2019s disease in a Mexican population. Clin Genet 51:225\u2013230","journal-title":"Clin Genet"},{"key":"9610_CR22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mds.870110204","volume":"11","author":"Huntington Study Group","year":"1996","unstructured":"Huntington Study Group (1996) Unified Huntington\u2019s disease rating scale: reliability and consistency. Mov Disord 11:136\u2013142","journal-title":"Mov Disord"},{"key":"9610_CR23","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR (1975) \u201cMini- mental state\u201d: a practical method for grading the cognitive state of subjects for the clinician. J Psychiatr Res 12:189\u2013198","journal-title":"J Psychiatr Res"},{"key":"9610_CR24","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1212\/WNL.49.4.1096","volume":"49","author":"JT Moroney","year":"1997","unstructured":"Moroney JT, Bagiella E, Desmond DW et\u00a0al (1997) Meta-analysis of the Hachinski Ischemic score in pathologically verified dementias. Neurology 49:1096\u20131105","journal-title":"Neurology"},{"issue":"suppl","key":"9610_CR25","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/0022-510X(94)90191-0","volume":"124","author":"BR Brooks","year":"1994","unstructured":"Brooks BR (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis: subcommittee on motor neuron diseases\/amyotrophic lateral sclerosis of the World Federation of Neurology research group on neuromuscular diseases and the El Escorial \u201cclinical limits of amyotrophic lateral sclerosis\u201d workshop contributors. J Neurol Sci 124(suppl):96\u2013107","journal-title":"J Neurol Sci"},{"key":"9610_CR26","doi-asserted-by":"crossref","unstructured":"ALS CNTF Treatment Study Phase I-II Study Group (1996) The ALS functional rating scale: assessment of activities of daily living in patients with amyotrophic lateral sclerosis. Arch Neurol 53:141\u2013147","DOI":"10.1001\/archneur.1996.00550020045014"},{"issue":"5","key":"9610_CR27","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1023\/A:1022853531855","volume":"28","author":"MC Boll","year":"2003","unstructured":"Boll MC, Alcaraz-Zubeldia M, Montes S, Murillo-Bonilla LM, Rios C (2003) Raised nitrates level and low SOD activity in the CSF in sporadic ALS. Neurochem Res 28(5):699\u2013703","journal-title":"Neurochem Res"},{"key":"9610_CR28","first-page":"129","volume":"15","author":"JMC Gutteridge","year":"1990","unstructured":"Gutteridge JMC, Halliwell B (1990) The measurement and mechanism of lipid peroxidation in biological systems. TIBS 15:129\u2013135","journal-title":"TIBS"},{"key":"9610_CR29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0079-6123(08)63214-8","volume":"118","author":"AG Estevez","year":"1998","unstructured":"Estevez AG, Spear N, Manuel SM et\u00a0al (1998) Role of endogenous nitric oxide and peroxynitrite formation in the survival and death of motor neurons in culture. Prog Brain Res 118:269\u2013280","journal-title":"Prog Brain Res"},{"key":"9610_CR30","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0891-5849(02)00901-2","volume":"33","author":"P Brookes","year":"2002","unstructured":"Brookes P, Levonen AL, Shiva S et\u00a0al (2002) Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Rad Biol Med 33:755\u2013764","journal-title":"Free Rad Biol Med"},{"key":"9610_CR31","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1517\/14728222.11.11.1415","volume":"11","author":"JC Corona","year":"2007","unstructured":"Corona JC, Tovar-y-Romo LB, Tapia R (2007) Glutamate excitotoxicity and therapeutic targets for amyotrophic lateral sclerosis. Expert Opin Ther Targets 11:1415\u20131428","journal-title":"Expert Opin Ther Targets"},{"key":"9610_CR32","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1212\/01.WNL.0000144276.29988.C3","volume":"63","author":"H Hochstrasser","year":"2004","unstructured":"Hochstrasser H, Bauer P, Walter U et\u00a0al (2004) Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 63:1912\u20131917","journal-title":"Neurology"},{"key":"9610_CR33","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.1523\/JNEUROSCI.22-15-06578.2002","volume":"2215","author":"BN Patel","year":"2002","unstructured":"Patel BN, Dunn RJ, Jeong SY et\u00a0al (2002) Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J Neurosci 2215:6578\u20136586","journal-title":"J Neurosci"},{"key":"9610_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3233\/JAD-2005-8212","volume":"8","author":"TA Bayer","year":"2005","unstructured":"Bayer TA, Multhaup G (2005) Involvement of amyloid beta precursor protein (AbetaPP) modulated copper homeostasis in Alzheimer\u2019s disease. J Alzheimers Dis 8:201\u2013206","journal-title":"J Alzheimers Dis"},{"key":"9610_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0361-9230(01)00453-1","volume":"55","author":"DR Brown","year":"2001","unstructured":"Brown DR (2001) Copper and prion disease. Brain Res Bull 55:165\u2013173","journal-title":"Brain Res Bull"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-008-9610-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11064-008-9610-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-008-9610-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,2]],"date-time":"2020-05-02T08:11:08Z","timestamp":1588407068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11064-008-9610-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2,29]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["9610"],"URL":"https:\/\/doi.org\/10.1007\/s11064-008-9610-3","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2,29]]}}}